These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24048898)

  • 1. Identification of the cellular sentinels for native immunogenic heat shock proteins in vivo.
    Messmer MN; Pasmowitz J; Kropp LE; Watkins SC; Binder RJ
    J Immunol; 2013 Oct; 191(8):4456-65. PubMed ID: 24048898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High efficiency CD91- and LOX-1-mediated re-presentation of gp96-chaperoned peptides by MHC II molecules.
    Matsutake T; Sawamura T; Srivastava PK
    Cancer Immun; 2010 Aug; 10():7. PubMed ID: 20672796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypically distinct helper NK cells are required for gp96-mediated anti-tumor immunity.
    Sedlacek AL; Kinner-Bibeau LB; Binder RJ
    Sci Rep; 2016 Jul; 6():29889. PubMed ID: 27431727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvanticity of alpha 2-macroglobulin, an independent ligand for the heat shock protein receptor CD91.
    Binder RJ; Karimeddini D; Srivastava PK
    J Immunol; 2001 Apr; 166(8):4968-72. PubMed ID: 11290775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of tumor-associated immunity requires interaction of heat shock proteins with CD91.
    Zhou YJ; Messmer MN; Binder RJ
    Cancer Immunol Res; 2014 Mar; 2(3):217-28. PubMed ID: 24778318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD91-dependent programming of T-helper cell responses following heat shock protein immunization.
    Pawaria S; Binder RJ
    Nat Commun; 2011 Nov; 2():521. PubMed ID: 22045000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein gp96 and cancer immunotherapy.
    Peibin Y; Shude Y; Changzhi H
    Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96.
    Strbo N; Oizumi S; Sotosek-Tokmadzic V; Podack ER
    Immunity; 2003 Mar; 18(3):381-90. PubMed ID: 12648455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis.
    Singh-Jasuja H; Toes RE; Spee P; Münz C; Hilf N; Schoenberger SP; Ricciardi-Castagnoli P; Neefjes J; Rammensee HG; Arnold-Schild D; Schild H
    J Exp Med; 2000 Jun; 191(11):1965-74. PubMed ID: 10839811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.
    Udono H; Levey DL; Srivastava PK
    Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3077-81. PubMed ID: 7909157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phylogenetic conservation of gp96-mediated antigen-specific cellular immunity: new evidence from adoptive cell transfer in xenopus.
    Maniero GD; Robert J
    Transplantation; 2004 Nov; 78(10):1415-21. PubMed ID: 15599304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells.
    Binder RJ; Harris ML; Ménoret A; Srivastava PK
    J Immunol; 2000 Sep; 165(5):2582-7. PubMed ID: 10946285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phylogenetic conservation of the molecular and immunological properties of the chaperones gp96 and hsp70.
    Robert J; Ménoret A; Basu S; Cohen N; Srivastava PR
    Eur J Immunol; 2001 Jan; 31(1):186-95. PubMed ID: 11265634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
    Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation.
    Li Z; Srivastava PK
    EMBO J; 1993 Aug; 12(8):3143-51. PubMed ID: 8344253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tunable heat shock protein-mediated NK cell responses are orchestrated by STAT1 in Antigen Presenting Cells.
    Sedlacek AL; Kinner-Bibeau LB; Wang Y; Mizes AP; Binder RJ
    Sci Rep; 2021 Aug; 11(1):16106. PubMed ID: 34373574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.